Coprescribing GLP-1 Receptor Agonists and Lifestyle
To the Editor The importance of integrating lifestyle modification when initiating glucagon-like peptide-1 and dual receptor agonists (GLP-1 RAs) for type 2 diabetes and/or obesity cannot be overstated. As referral to a registered dietitian or lifestyle medicine specialist is ideal but not always feasible, providing clinicians with practical, evidence-based resources for use when coprescribing GLP-1 […]
Coprescribing GLP-1 Receptor Agonists and Lifestyle—Reply
In Reply We thank Rockwell et al for their letter and the opportunity to clarify the below points about our article.
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war – The Guardian
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war The Guardian Starter dose of Wegovy now available as a daily pill instead of weekly injection CNN Wegovy obesity pill now available at pharmacies : Shots – Health News NPR What to watch for in weight loss drugs in 2026: Price changes, GLP-1 pills and more NBC News […]
Something Grim Is Happening to People Who Go Off GLP-1s – Yahoo News New Zealand
Something Grim Is Happening to People Who Go Off GLP-1s Yahoo News New Zealand Older Americans are quitting GLP-1 weight-loss drugs for 4 key reasons Fox News What Is the Impact of GLP-1s in Older Adults with Obesity? Yale School of Medicine
Novo Nordisk debuts Wegovy weight-loss pill in the U.S. – CBS News
Novo Nordisk debuts Wegovy weight-loss pill in the U.S. CBS News Starter dose of Wegovy now available as a daily pill instead of weekly injection CNN Wegovy obesity pill now available at pharmacies : Shots – Health News NPR First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. CNBC What to watch for in weight loss […]
Starter dose of Wegovy now available as a daily pill instead of weekly injection – CNN
Starter dose of Wegovy now available as a daily pill instead of weekly injection CNN First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. CNBC Novo Nordisk debuts Wegovy weight-loss pill in the U.S. CBS News What to watch for in weight loss drugs in 2026: Price changes, GLP-1 pills and more NBC News Novo Nordisk […]
MetaVia weighs in with 9% loss as dual agonist enters the obesity ring
MetaVia has shared an update on its attempt to crash the obesity party, reporting average weight loss of 9.1% in people who received its dual agonist of GLP-1 and glucagon in a phase 1 trial.
Weight Loss: What I Wish I’d Known Before Taking Compounded Semaglutide
Semaglutide erased the constant mental chatter about food that had ruled her life, but along with it went her awareness of basic needs. Writer Kristen Reed shares her weight loss journey with compounded semaglutide. Photography courtesy of Kristen Reed Health and wellness touch everyone’s life differently. This is one person’s story. The views and opinions […]
Wegovy daily pill now available: How to get it, how much it costs – ABC News
Wegovy daily pill now available: How to get it, how much it costs ABC News First pill version of Wegovy for obesity launches in US The Hill First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. CNBC What to watch for in weight loss drugs in 2026: Price changes, GLP-1 pills and more NBC News Novo […]
A Pill Version of Wegovy Hits Pharmacies
In the last week of December, while most of the U.S. was still in holiday mode, Novo Nordisk’s plant in North Carolina was operating at full capacity. On Dec. 22, the U.S. Food and Drug Administration (FDA) approved the company’s oral version of Wegovy, making it the first pill of the popular GLP-1 medications to […]